The filing was completed on November 3, 2013. The FDA has 90 days to respond if they have any questions regarding our application and if it should be ammended in anyway. We have not been notified of any exceptions so far and now it is a waiting game. There is no defininte date, but we are eagerly anticipating a response by the end of February 2014.
As this is a material change in our company, once we receive approval the investing public will know immediately.
Thank you for your interest and support in our company.